Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.

"ABM-C is an advisory board member for Siemens, outside of the submitted work. MDR and EC have been granted by and received honoraria from Jazz Pharmaceuticals. PC and SF have collaborated with Jansen, Gilead, Kite, MSD, Alexion, and Pfizer, outside of the submitted work. MP received speaker's fee from Jazz Pharmaceuticals. CCC has received research support from ADC Therapeutics and Rhizen Pharmaceuticals; has served as consultant or advisor for Servier, Novartis, Genenta Science srl, ADC Therapeutics, Roche, Sanofi, Karyopharm, and Jazz Pharmaceuticals; and has received honoraria for speaker engagements from Bristol-Myers Squibb, Merck Sharp & Dohme, Janssen Oncology, Astra-Zeneca. JMM reports grants and consulting honoraria from Jazz Pharmaceuticals, during the conduct of the study; consulting honoraria and travel expenses from Gilead, consulting honoraria from Novartis, Sandoz, and Takeda, outside the submitted work. PGR reports a consulting or advisory role for Karyopharm, Oncopeptides, Celgene, Janssen, Takeda, and Sanofi; and research funding from Oncopeptides, Celgene, Takeda, and Bristol-Myers Squibb . The rest of authors have no actual or potential conflict of interest to declare."

"The authors thank Patricia Molina, Laura Bonastre, Estefanía Garcia, Pilar Gómez, and Marc Pino for their technical assistance. This study was supported by Fundació Clínic, Barcelona (HCB/2020/0401) and Jazz Pharmaceuticals (IST-16–10355). Results from the present study were presented in part at the ASH 62th Annual Meeting (2020). This study was supported by Fundació Clíinc, Barcelona (HCB/2020/0401), Jazz Pharmaceuticals (IST-16-10355), Fundació La Marató de TV3 (Project Code: 202026) and Instituto Carlos III, Spanish Government, FIS PI12/00832 cofinanciado con Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa."